Cargando…
Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Autor principal: | International, BioMed Research |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805830/ https://www.ncbi.nlm.nih.gov/pubmed/36597467 http://dx.doi.org/10.1155/2022/9808495 |
Ejemplares similares
-
Retracted: Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC)
por: International, BioMed Research
Publicado: (2023) -
Retracted: The Anesthetic Effect and Safety of Dexmedetomidine in Cesarean Section: A Meta-Analysis
por: International, BioMed Research
Publicado: (2023) -
Retracted: Correlation of CCNA1 Promoter Methylation with Malignant Tumors: A Meta-Analysis Introduction
por: International, BioMed Research
Publicado: (2021) -
Retracted: Influence of Two Common Polymorphisms in the EPHX1 Gene on Warfarin Maintenance Dosage: A Meta-Analysis
por: BioMed Research International,
Publicado: (2019) -
Retracted: Treatment Protocols in the Efficacy and Safety of Anti-EGFR Medicines in Combination with Standard Therapy for Patients with Nasopharyngeal Cancer: A Meta-Analysis
por: International, BioMed Research
Publicado: (2023)